A self-retracting, position-limiting insulin injector
By designing a detachable, limiting insulin injector, the syringe can be replaced, solving the problems of high cost and waste associated with traditional syringes, and enabling the use of an economical and environmentally friendly syringe.
Patent Information
- Application Number
- CN202522472982.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-11-21
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2035-11-21
AI Technical Summary
Traditional insulin injectors with automatic needle retraction are disposable and costly, and generate a high frequency of medical waste, increasing the burden on patients and environmental pressure.
Design a detachable limiting insulin injector. Through the coordinated operation of the transmission injection component and the tail power component, the syringe can be replaced. The automatic retraction of the needle and the simple disassembly and replacement of the syringe are achieved by using magnetic adsorption and a rotating shaft structure.
It reduced production costs, decreased the generation of medical waste, improved environmental protection, and enhanced the practicality and functionality of syringes, thus meeting actual needs.
Smart Images

Figure CN224975482U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical device technology, and in particular to a limiting insulin injector with automatic needle retraction. Background Technology
[0002] The self-retracting insulin injector is a medical device with a safety protection mechanism, mainly used for insulin injection in diabetic patients. Its core feature is that the needle can automatically retract after injection, avoiding needle exposure and reducing the risk of reuse and cross-infection.
[0003] In traditional insulin injectors with automatically retractable needles, diabetic patients need to inject insulin frequently and over a long period. The single-use model requires patients to continuously purchase new syringes, increasing their financial burden. Furthermore, the large-scale demand for disposable syringes places higher demands on the efficiency and stability of the medical supply chain. This not only increases the load on medical waste disposal systems but may also have potential environmental impacts due to the generation of harmful gases from incineration and the occupation of land resources for landfill. Utility Model Content
[0004] To address the issues of high cost and frequent medical waste generation associated with traditional self-retracting insulin syringes, this invention proposes a self-retracting insulin syringe. By adjusting the overall structure, it achieves simple and quick reusability. Only a minor adjustment is needed to detach the used syringe from the structure for replacement with a new one. This significantly reduces costs and improves environmental friendliness while ensuring its safe single-use nature as a medical device.
[0005] To achieve the above objectives, the present invention adopts the following technical solution: a limiting insulin injector with automatic needle retraction, comprising an external connecting component, a transmission injection component, and a tail power component, wherein the transmission injection component is disposed on the tail power component, and the external connecting component is sleeved on the outer surface of the transmission injection component and the tail power component.
[0006] The transmission injection assembly includes an upper sleeve, a lower sleeve, an upper push shell, a lower push shell, and a syringe. The upper and lower sleeves are snapped together on opposite sides and cover the entire transmission injection assembly. The lower sleeve has protruding connecting rods on both sides of its outer surface, which confine the assembly within the external connecting assembly to prevent it from coming out. The upper and lower push shells are snapped together on opposite sides and cover the syringe. The lower push shell has symmetrically placed limiting buckles on its inner surface, which restrict the position of the upper and lower sleeves and keep them locked before the device is used. The tapered end faces of the upper and lower push shells are fitted with a syringe spring, which is used to reset the transmission injection assembly.
[0007] Preferably, a needle is connected to one end of the syringe, a piston is fitted on the inner wall of the syringe, and a core rod is fixedly connected to one side of the outer surface of the piston.
[0008] Preferably, the tail power assembly includes an upper tail sleeve and a lower tail sleeve. One end of the outer surface of both the upper and lower tail sleeves is provided with a first fitting mechanism. The first fitting mechanisms of the upper and lower tail sleeves are connected through a rotating shaft.
[0009] Preferably, the inner walls of the upper tail sleeve and the lower tail sleeve are jointly fitted with an upper limit cylinder and a lower limit cylinder, and the opposite sides of the upper limit cylinder and the lower limit cylinder are magnetically connected.
[0010] Preferably, a locking rod is inserted between the inner walls of the upper limit cylinder and the lower limit cylinder, and the locking rod is in full contact with the opposite end of the core rod.
[0011] Preferably, a locking spring is fitted onto the outer surface of the locking rod.
[0012] Preferably, the external coupling assembly includes an upper housing and a lower housing, with a second fitting mechanism provided on the opposite side of the upper housing and the lower housing, and a magnet embedded on the opposite side of the upper housing and the lower housing.
[0013] Compared with the prior art, the advantages and positive effects of this utility model are as follows:
[0014] In this invention, the transmission injection assembly and the tail power assembly work together to achieve rotational opening and closing through a snap-fit connecting the upper and lower propulsion shells and magnetic adsorption. The fitting mechanism of the upper and lower tail sleeves is achieved through a rotating shaft. A linkage structure is added between the various mechanisms, making the syringe barrel replaceable. After injection, the spring at the barrel retracts the needle, and the syringe barrel can be replaced with a simple operation. This avoids the high cost of single-use traditional devices and the problem of high frequency of medical waste, which significantly reduces production costs. It effectively balances practicality and functionality in daily use and is more suitable for actual needs than the traditional single mode. Attached Figure Description
[0015] Figure 1 This is a perspective view of the main structure of a limiting insulin injector with automatic needle retraction proposed in this utility model.
[0016] Figure 2 This is a schematic diagram of the internal structure of a limiting insulin injector with automatic needle retraction proposed in this utility model;
[0017] Figure 3 This is a schematic diagram showing the installation position of a limiting insulin injector with automatic needle retraction proposed in this utility model.
[0018] Figure 4 This is a schematic diagram of the internal structure of the injection syringe in a limiting insulin injector with automatic needle retraction proposed in this utility model.
[0019] Figure 5 This is a schematic diagram showing the installation position of the limiting buckle in a limiting insulin injector with automatic needle retraction proposed in this utility model.
[0020] Figure 6 This is a schematic diagram showing the installation position of the housing fitting mechanism in a limiting insulin injector with automatic needle retraction proposed in this utility model.
[0021] Legend: 1. External connecting assembly; 101. Upper housing; 102. Lower housing; 103. Magnet; 2. Transmission injection assembly; 201. Upper sleeve; 202. Lower sleeve; 203. Upper propulsion shell; 204. Lower propulsion shell; 205. Limiting buckle; 206. Cylinder spring; 207. Syringe; 208. Needle; 209. Piston; 210. Core rod; 3. Tail power assembly; 301. Upper tail sleeve; 302. Lower tail sleeve; 303. Rotating shaft; 304. Upper limit cylinder; 305. Lower limit cylinder; 306. Locking rod; 307. Locking spring. Detailed Implementation
[0022] To better understand the above-mentioned objectives, features, and advantages of this utility model, the present utility model will be further described below with reference to the accompanying drawings and embodiments. It should be noted that, unless otherwise specified, the embodiments and features described in these embodiments can be combined with each other.
[0023] Many specific details are set forth in the following description in order to provide a full understanding of the present invention. However, the present invention may also be implemented in other ways different from those described herein. Therefore, the present invention is not limited to the specific embodiments disclosed in the following specification.
[0024] In the embodiments, according to Figures 1-2As shown, this utility model provides a technical solution: a limiting insulin injector with automatic needle retraction, including an external connecting component 1, a transmission injection component 2, and a tail power component 3. The transmission injection component 2 is disposed on the tail power component 3, and the external connecting component 1 is sleeved on the outer surface of the transmission injection component 2 and the tail power component 3.
[0025] The tail power assembly 3 includes an upper tail sleeve 301 and a lower tail sleeve 302. One end of the outer surface of the upper tail sleeve 301 and the lower tail sleeve 302 is provided with a first fitting mechanism. The first fitting mechanisms of the upper tail sleeve 301 and the lower tail sleeve 302 are connected through a rotating shaft 303. The inner walls of the upper tail sleeve 301 and the lower tail sleeve 302 are jointly fitted with an upper limit cylinder 304 and a lower limit cylinder 305. The opposite sides of the upper limit cylinder 304 and the lower limit cylinder 305 are magnetically connected.
[0026] A locking rod 306 is inserted between the inner walls of the upper limit cylinder 304 and the lower limit cylinder 305, and the locking rod 306 is in full contact with the opposite end of the core rod 210. A locking spring 307 is sleeved on the outer surface of the locking rod 306. The external coupling assembly 1 includes an upper housing 101 and a lower housing 102. A second fitting mechanism is provided on the opposite side of the upper housing 101 and the lower housing 102, and a magnet 103 is embedded on the opposite side of the upper housing 101 and the lower housing 102.
[0027] Specifically: When using this device for insulin injection, firstly, the tail end of the injection syringe is inserted into the upper limit cylinder 304 and the lower limit cylinder 305, and a locking rod 306 is connected to the tail end of the injection syringe. The locking rod 306 is fitted with a locking spring 307. The locking rod 306 is restricted in the groove of the upper limit cylinder 304 and the lower limit cylinder 305, so that the locking spring 307 is kept locked. The upper tail sleeve 301 and the lower tail sleeve 302 are sleeved on the outside of the upper limit cylinder 304 and the lower limit cylinder 305. The fitting mechanism of the upper tail sleeve 301 and the lower tail sleeve 302 is connected and closed by a rotating shaft 303. The upper shell 101 and the lower shell 102 are fitted on the outer ring as a whole. The upper shell 101 and the lower shell 102 are rotated through the fitting mechanism at their top ends. After closing, they are fastened together by a magnet 103.
[0028] In some embodiments, according to Figure 2As shown, the transmission injection assembly 2 includes an upper sleeve 201, a lower sleeve 202, an upper push shell 203, a lower push shell 204, and a syringe 207. The upper sleeve 201 and the lower sleeve 202 are snapped together on opposite sides and are responsible for covering the entire transmission injection assembly 2. The lower sleeve 202 has protruding connecting rods on both sides of its outer surface. The two protruding connecting rods are responsible for confining the assembly in the external connecting assembly 1 to prevent it from falling out. The upper push shell 203 and the lower push shell 204 are snapped together on opposite sides and are used to cover the syringe 207. The lower push shell 204 has symmetrically provided limiting buckles 205 on its inner surface. The two limiting buckles 205 are responsible for limiting the position of the upper sleeve 201 and the lower sleeve 202 and keeping the upper sleeve 201 and the lower sleeve 202 locked before the device is used.
[0029] The upper push shell 203 and the lower push shell 204 are both fitted with a cylinder spring 206, and the cylinder spring 206 is used to drive the injection assembly 2 to reset. One end of the syringe 207 is connected to a needle 208. The inner wall of the syringe 207 is fitted with a piston 209, and a core rod 210 is fixedly connected to one side of the outer surface of the piston 209.
[0030] The overall effect of this embodiment is as follows: The above components form a complete insulin injector with automatic needle retraction. The external connecting component 1 provides a enclosure for the entire device. Opening and closing are achieved through the rotational structure of the upper housing 101 and the lower housing 102, and are attracted by a magnet 103. An upper sleeve 201 and a lower sleeve 202 are fitted inside the housing, connected by a snap-fit. Two protruding connecting rods on the outer surface of the lower sleeve 202 ensure that it can only move within the groove range of the external connecting component 1 to prevent it from falling out. An upper push shell 203 and a lower push shell 204 are fitted inside the sleeve. The device is connected by a snap-fit mechanism. A limiting snap-fit 205 is located at the hollowed-out part of the lower push-out shell 204. Before use, the limiting snap-fit 205 remains stationary due to the plastic's toughness, locking the upper sleeve 201 and lower sleeve 202 in place. A cylinder spring 206 is fitted onto the conical end faces of the upper push-out shell 203 and lower push-out shell 204. When the device is in use, the user holds the shell and presses the sleeve against their skin. At this time, the push-out shell presses against the upper limiting cylinder 304 and lower limiting cylinder 305 at the tail end, causing them to compress and push the locking rod 306 into the bottom groove of the upper tail sleeve 301 and lower tail sleeve 302. When the protruding part of syringe 6 is compressed, the locking rod 306 retracts, unlocking and entering the limiting cylinder. At this time, the locking spring 307 is released and pops out, pressing the locking rod 306 against the core rod 210, causing the syringe 207 to advance, thus allowing the needle 208 to protrude and pierce the skin. The locking spring 307 continues to apply pressure, causing the core rod 210 to push the piston 209 to release the medication. As the syringe 207 advances, it will strike the limiting buckle 205, thereby unlocking the movement of the sleeve. When the injection is completed, releasing the syringe will cause the barrel spring 206 to release pressure, pressing against the sleeve and causing it to advance, thus retracting the needle 208 into the sleeve, achieving... The needle 208 retracts automatically. When the syringe needs to be replaced, first open the housing fixed by the magnet 103, then rotate the tail tube apart by the rotating shaft 303, and separate the upper sleeve 201 and the upper push-up housing 203 by the buckle. Take out the syringe and put in the new syringe. Then restore each part in sequence. Compared with traditional devices, this device avoids the problem of high economic cost of single use and high frequency of medical waste generated by traditional devices, greatly reducing production costs. It effectively balances practicality and functionality in daily use and can greatly improve production efficiency.
[0031] The above are merely preferred embodiments of the present utility model and are not intended to limit the present utility model in any other way. Any person skilled in the art may make changes to the above-disclosed technical content and apply equivalent embodiments to other fields. However, any simple modifications, equivalent changes and alterations made to the above embodiments based on the technical essence of the present utility model without departing from the technical solution of the present utility model shall still fall within the protection scope of the technical solution of the present utility model.
Claims
1. A limiting insulin injector with automatic needle retraction, characterized in that: It includes an external coupling component (1), a transmission injection component (2) and a tail power component (3), wherein the transmission injection component (2) is disposed on the tail power component (3), and the external coupling component (1) is sleeved on the outer surface of the transmission injection component (2) and the tail power component (3); The transmission injection assembly (2) includes an upper sleeve (201), a lower sleeve (202), an upper push shell (203), a lower push shell (204), and a syringe (207). The upper sleeve (201) and the lower sleeve (202) are snapped together on opposite sides, and the upper sleeve (201) and the lower sleeve (202) are responsible for covering the entire transmission injection assembly (2). The lower sleeve (202) has protruding connecting rods on both sides of its outer surface. The two protruding connecting rods are responsible for confining the assembly in the external connecting assembly (1) to prevent it from falling out. The upper push shell (203) and the lower push shell (204) are snapped together on opposite sides. The upper and lower push shells (204) are connected by a snap fastener on one side and are used to cover the syringe (207). The inner surface of the lower push shell (204) is symmetrically provided with limiting snap fasteners (205). The two limiting snap fasteners (205) are responsible for limiting the position of the upper sleeve (201) and the lower sleeve (202) and keeping the upper sleeve (201) and the lower sleeve (202) locked before the device is used. The tapered end faces of the upper push shell (203) and the lower push shell (204) are jointly fitted with a syringe spring (206), and the syringe spring (206) is used to drive the reset of the injection assembly (2).
2. The self-retracting, limiting insulin injector according to claim 1, characterized in that: One end of the syringe (207) is connected to a needle (208), and a piston (209) is sleeved on the inner wall of the syringe (207). A core rod (210) is fixedly connected to one side of the outer surface of the piston (209).
3. A limiting insulin injector with automatic needle retraction according to claim 2, characterized in that: The tail power assembly (3) includes an upper tail sleeve (301) and a lower tail sleeve (302). One end of the outer surface of the upper tail sleeve (301) and the lower tail sleeve (302) is provided with a first fitting mechanism. The first fitting mechanisms of the upper tail sleeve (301) and the lower tail sleeve (302) are connected through a rotating shaft (303).
4. A limiting insulin injector with automatic needle retraction according to claim 3, characterized in that: The upper tail sleeve (301) and the lower tail sleeve (302) are fitted together with an upper limit cylinder (304) and a lower limit cylinder (305), and the upper limit cylinder (304) and the lower limit cylinder (305) are magnetically connected on opposite sides.
5. A limiting insulin injector with automatic needle retraction according to claim 4, characterized in that: A locking rod (306) is inserted between the inner walls of the upper limit cylinder (304) and the lower limit cylinder (305), and the locking rod (306) is in full contact with the opposite end of the core rod (210).
6. A limiting insulin injector with automatic needle retraction according to claim 5, characterized in that: A locking spring (307) is fitted onto the outer surface of the locking rod (306).
7. A limiting insulin injector with automatic needle retraction according to claim 1, characterized in that: The external coupling assembly (1) includes an upper housing (101) and a lower housing (102). A second fitting mechanism is provided on the opposite side of the upper housing (101) and the lower housing (102), and a magnet (103) is embedded on the opposite side of the upper housing (101) and the lower housing (102).
